STD Asia Pacific Congress 2019

Theme: Advancements, Novel approaches for prevention & control of STD and Infectious Diseases

STD Asia Pacific Congress 2019

9th Asia Pacific STD and Infectious Diseases Congress

October 21-22, 2019 Tokyo Japan

Theme: Advancements, Novel approaches for prevention & control of STD and Infectious Diseases

On behalf of Conference series LLC LTD., we take immense pleasure in inviting all the participants over the world to attend the “9th Asia Pacific STD and Infectious Diseases Congress” which will be held during October 21-22, 2019 at Tokyo Japan with the theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”.

Why to attend?

The present research on Emerging technologies and Strategies, Prevention and advanced Diagnosis, improvements, the most current updates in HIV, AIDS, STD and infectious diseases are hallmarks of this Conference. Lead introductions, disseminate data, foster networking with present and potential specialists, make a splash with latest improvements, and participation acknowledgment at this II day occasion. STD Asia Pacific Congress 2019 makes you move, learn and embrace better approaches to enhance Medical professional career prospects.

Target Audience:

Medical Professionals & Physicians
Nurse-practitioners & Pharmacists
Psychologists & Abuse, Behavioral specialists
Infectious diseases doctors & Public Health care Researchers
Social workers, AIDS service organization (ASO) staff
National government agencies and consultants
Epidemiologists, Bacteriologist, Retro-virologists, Microbiologists, Oncologists
Geneticist, Gynaecologists, Clinical experts
Business experts / Manufactures & suppliers/ Aspiring Entrepreneurs, Sales Manager.
Media partners and Collaborators
International Delegates and global observers
Students and Young Researchers.

STD Asia Pacific Congress 2019 is the reputed conference which aims to provide best platform to explore the emerging strategies for the prevention and treatment of sexually transmitted diseases.

Join us for a symphony of outstanding science, and enjoy the spectacular and unique beauty of Tokyo, Japan.

For long lasting scientific relation follow us https://std.conferenceseries.com/asiapacific/

Thanks and Regards

STD Asia Pacific Congress 2019

Email: stdasia@conferenceint.com | stdasia@conferencesseries.org

Welcome to STD Asia Pacific Congress 2019 !!!

On behalf of STD Asia Pacific Congress 2019, we take immense pleasure in inviting all the participants over the world to attend the “9th Asia Pacific STD and Infectious Diseases Congress”(STD Asia pacific 2019)which will be held during October 21-22, 2019 at Tokyo Japan with the theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”.

Why to attend?

Key Reasons:

World Class Speakers and Emerging new Talent from across the Globe in Health Industry
Packed Schedule: Workshops, Multi-track Conference, Expo area and more
To educate yourself on the diagnosis and treatment of STD and Infectious diseases.
To enhance your ability to treat the growing number of patients affected by these diseases.
To network with your fellow primary care clinicians.
To empower yourself to fill the void created by the national shortage of participants.

Target Audience:

Medical Professionals & Physicians
Nurse-practitioners & Pharmacists
Psychologists & Abuse, Behavioral specialists
Infectious diseases doctors & Public Health care Researchers
Social workers, AIDS service organization (ASO) staff
National government agencies and consultants
Epidemiologists, Bacteriologist, Retro-virologists, Microbiologists, Oncologists
Geneticist, Gynaecologists, Clinical experts
Business experts / Manufactures & suppliers/ Aspiring Entrepreneurs, Sales Manager.
Media partners and Collaborators
International Delegates and global observers
Students and Young Researchers.

STD Congress 2019 Conference Unique Opportunities

For Researchers and Faculty Members:

Speaker Presentations

Poster Display

Symposium hosting (4-5-member team)

Workshop organizing

For Universities, Associations & Societies:

Association Partnering

Collaboration proposals

Academic Partnering

Group Participation

For Students and Research Scholars:

Poster Competition (Winner will receive Best Poster Award)

Young Researcher Forum (YRF Award to the best presenter)

Student Attendee

Group Registrations

For Business Delegates:

Speaker Presentations

Symposium hosting

Book Launch event

Networking opportunities

Audience participation

For Business Entities :

Exhibitor and Vendor Booths

Sponsorship opportunities

Product launch

Workshop organizing

Scientific Partnering

Marketing and Networking with clients

STD Asia Pacific Congress 2019 is the reputed conference which aims to provide best platform to explore the emerging strategies for the prevention and treatment of sexually transmitted diseases.

All accepted abstracts will be published in respective Scientific International Journals. Abstracts will be provided with Digital Object Identifier Cross reference. Selected contributions will be published in following subject related international Journals

Journal of AIDS & Clinical Research
Journal of HIV & Retro Virus
Journal of Primary & Acquired Immunodeficiency Research
Journal of Antivirals and Antiretroviral
Journal of Infectious Diseases & Therapy

Join us for a symphony of outstanding science, and enjoy the spectacular and unique beauty of Tokyo, Japan.

Track 1: STD and Infectious Diseases

The term ‘Sexually Transmitted Diseases’ (curtailed STDs) alludes to a cluster of sicknesses that can be transmitted beginning with one individual then onto the following through the sharing of body liquids including discharge, vaginal liquids, blood, and distinctive fluids. They have a wide range of causes (counting microscopic organisms & Infections), they deliver an assortment of manifestations (or nonattendance of side effects), and they have altogether different impacts on the body when left untreated which is specified as STD symptoms. There are various types of STDs from benign to malignant and harmful ones. Nearly twenty various infections are known to be transmitted through sexual contacts. Most Sexually Transmitted Diseases affect both men and women, but in most of the cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause consequential health problems for the baby.

Sexually transmitted ailments are transmitted when body fluids from a polluted individual come into indicate contact with another person. As their name infers, the most well-known course through which this body fluid sharing happens is sexual activity.

Track 2: Determinants of STI transmission

Exposure of susceptible to infected individuals can be influenced through counselling of patients to reduce early sexual debut and concurrent sexual partners, and to promote the performance of safer sexual activities, including:

· Non-penetrative sexual acts

· Consistent and correct use of condom

· STI & HIV Testing followed by commitment to monogamy.

The efficiency of transmission during exposure between the susceptible and infectious partners can be influenced by number of primary care physician interventions. Counselling and advising patients to use “safer sex” practices such as condom and avoidance of the unprotected vaginal or anal intercourse which can be substantially reduce the transmission of STI pathogens. The applications of epidemiologic treatment to patients who had a known exposure to a STI can reduce transmission presumably by treating patients either before symptoms develop or during the incubation period of the infection. Other forms of post-exposure prophylaxis have been used to prevent HIV infection following needle - stick, or sexual assault exposure. Finally the physicians can reduce the infectivity of some of the infected individuals by the use of suppressive antimicrobial therapy.

Track 3 : STI Syndromes

The syndromic approach is an important tool in the control of STIs and their sequelae, management by syndrome alone is inadequate because infections with important infectious agents such as Chlamydia trachomatis and Neisseria gonorrhoeae can be present without any symptoms . It is important to recognize syndromes to findings that may be caused by one or more sexually transmitted pathogens and in managing STIs, diagnosis by syndrome and laboratory diagnosis by testing for a specific organism which are both important and complementary. Diagnosis of a syndrome or findings according to standard criteria predicts the likelihood that any specific pathogen is present and thus facilitates initiation of appropriate empiric treatment at the initial visit than deferring treatment until there is microbiological confirmation. WHO have developed simple flowcharts (called algorithms) to guide health care providers using the syndromic approach to manage seven syndrome.

Track 4 : Epidemiology of STI's

STI epidemiology and management has evolved interactively, particularly in the developing nations. Technological frontiers in the diagnosis, screening, and treatment evaluation and widespread implementation of new case-management algorithms; and changes in risk behaviors in response to the AIDS epidemic have all influenced the dynamic typology of STIs. For Every year worldwide, there are approximately 357 million of new infections of syphilis, chlamydia, gonorrhoea, and trichomoniasis. The major recent advances in the STI prevention is the early success of a prophylactic, monovalent human papillomavirus (HPV) type 16 vaccine, HPV vaccines may be able to prevent genital and anal cancers in foreseeable future.

Track 5 : Infection Prevention and Control (IPAC)

Infectious diseases prevention & control will helpful to prevent the transmission of infectious diseases. STI control efforts have been increased in relation to the HIV programme priorities that are funded, implemented and evaluated independently for other STI control efforts. STI control is the public health outcome, measured as reduced incidence and prevalence, achieved by implementing strategies composed of the multiple synergistic interventions.

Abnormal development of fetus resulting in the death, malformation, growth retardation, and functional disorders is defined as the birth defects. Nearly 150,000 babies are born annually with birth defects. Birth defects, including low birth weight babies, are the most leading cause of infant mortality. Chlamydia is the most common sexually transmitted diseases, affects an estimated 100,000 pregnant women every year, according to the Centers for Disease Control and Prevention. In fact, it is one of the serious causes of infections affecting newborns' eyes and respiratory system. Exposure to the bacteria during childbirth could lead to infection of the respiratory tract, causing infant pneumonia. While some types of birth defects have declined , mostly by preventive methods, many have increased. According to the CDC study of 38 types of birth defects occurring over the period 1979-89, 27 had increased, including several cardiac defects, chromosomal defects like trisomy 18, and fetal alcohol syndrome; 9 had remained the same , and only 2 had decreased. Prompt evaluation of the sexual partners is mandatory to prevent reinfection and disrupt transmission of many STDs. Preexposure vaccination is among the most effective methods for preventing some STDs.

Track 6: Vertical Transmission

Vertical transmission alos known as Prevention of Mother-To-Child Transmission (PMTCT) it is passage of a disease-causing agent (pathogen) from mother to baby during the period immediately before and after birth. Transmission might occur across the placenta, in the breast milk, or through direct contact during or after birth. For example, HIV can be a vertically transmitted pathogen. Also known as perinatal transmission.The rate of Developing Infectious Diseases is quickly expanding or debilitates to increment sooner rather than later. The ascent of new irresistible sicknesses or the re-development of the old irresistible ailments is supported by numerous components like advancement of the pathogens, human behavior and practice.

The developing sicknesses can be built up by its presentation into a populace and its capacity to spread starting with one individual then onto the next. Numerous rising and re-rising irresistible infections have been found like Hemorrhagic fever, Encephalitis, Zika virus & West nile virus etc

Track 7 : HIV/AIDS & STDs

HIV is the virus spread through certain body fluids which attacks the body’s immune system, specifically the CD4 cells, often called as T cells. AIDS is the severe phase of HIV infection. People with AIDS have badly damaged immune systems , they get an increasing number of severe illnesses, called opportunistic infections.

The three phases of HIV infection are:

(1) Acute HIV infection,

(2) Clinical latency, and

(3) AIDS (Acquired Immunodeficiency Syndrome)

HIV is the main cause of the spectrum of disease known as HIV/AIDS. HIV is a retrovirus which primarily infects components of the human immune system such as CD4+ T cells, macrophages and dendritic cells. It directly and indirectly destroys the CD4+ T cells

Human immune deficiency virus infection & Acquired immune deficiency syndrome (HIV/AIDS) is the spectrum of conditions caused due to infection with the human immunodeficiency virus (HIV). HIV is spread primarily by unprotected sex (including the anal and oral sex) contaminated blood transfusions, hypodermic needles, from Mother to child Transmission during the pregnancy, delivery, or breastfeeding. Diseases in the baby can often be prevented by giving both the mother and child anti-retroviral medication. HIV/AIDS research includes the medical research which attempts to prevent, treat and cure HIV/AIDS along with fundamental research about the nature of HIV as an infectious agent & AIDS as the disease caused by HIV. Governments aided organization and research institutions participate in the HIV/AIDS research which includes behavioral health interventions such as sex education, and drug development, such as research into microbicides for STD, HIV vaccines, and antiretroviral drugs. Medical research areas which include the topics of pre-exposure prophylaxis, post-exposure prophylaxis, circumcision and HIV. Public health officials, Researchers and programs can gain more comprehensive picture of the barriers they face, and the efficacy of present approaches for HIV treatment and prevention, by tracking the standard HIV indicators. Use of the common indicators is an increasing focus of development organizations and researchers.

Track 8 : Syphilis and STD

Syphilis is sexually transmitted diseases (STD) which have very serious complications when it was left untreated, but it is simple to cure with the correct treatment. Symptoms in adults are divided into phases. The phases can be divided into primary, secondary, latent, and late syphilis. Syphilis can be spread by direct contact with syphilis sore during the vaginal, anal or oral sex. Sores can be found on the penis, vagina, anus, in the rectum, on the lips and in the mouth. Syphilis alos called ‘the great imitator’ as it has so many possible symptoms, many of which look like symptoms from other diseases. The painless syphilis sore that get after first infected can be confused for an ingrown hair, zipper cut, or other seemingly harmless bump. The syphilis infected baby may be born without signs or symptoms of disease. If not it is not treated immediately, the baby may develop serious problems within a few weeks. Untreated babies can have serious health problems such as cataracts, deafness, or seizures and even can die.

Track 9 : Types of STDs & Infections

Depending on the type and form of disease, STDs can be spread with any type of sexual activity. STDs are mostly caused by viruses and bacteria, both bacterial and viral STDs which vary in the treatment and diagnosis. Bacterial STDs, mainly gonorrhea, syphilis, and chlamydia, are often cured with antibiotics. Viral STDs, commonly HIV, HPV (genital warts), Herpes and hepatitis (it is the only STD that can be prevented with a vaccines), have no cure, but their symptoms can be diminish with treatment. STDs, such as gonorrhea and syphilis, are classified into the "reportable" because when diagnosed they must be reported to the proper health or government agency to prevent their spread and transmission. Gonorrhea, one of the most widespread of the STDs, is caused by the bacterium Neisseria gonorrhoeae, some strains of which are resistant to treatment by penicillin, other drugs of choice. 80% women & 40 % men diagnosed with chlamydia may not experience any symptoms.

Track 10 : Re-emerging Infectious Diseases

Developing Infectious Diseases are those whose rate or the geographic range is fast expanding or debilitates to increment sooner rather than later. The ascent of new irresistible sicknesses or the re-development of the old irresistible ailments is supported by numerous components like advancement of the pathogens, human behavior and practice.

Track 11: Cancers- STD Infections

Having an STD/STI increases the person's risk for various types of cancer. Certain high-risk types of Human Papilloma Virus (HPV) can cause the cervical cancer in women and other cancers includes the cancer of the vulva, vagina. In men, HPV infection can lead to development of penile cancers. HPV also can cause cancers of mouth, throat, and anus in both sexes. It can also cause the oropharyngeal cancer. Acquiring viral hepatitis B or C puts the person at risk for liver cancer, and untreated HIV/AIDS increases the risk for several types of rare cancers, including lymphomas, sarcomas, and cervical cancer. There are the HPV tests that are used to screen for the cervical cancer. These tests are recommended for screening in the women aged 30 years and older. They are not recommended to screen the men, adolescents, or women under the age of 30 years.

Track 12 : Tuberculosis and Hepatitis Co-Infections

Most of the healthy people’s immune systems kill or contain TB infection without developing symptoms. Latent TB infection is the asymptomatic and non-transmissible form of TB. Hepatitis is the inflammation of liver. There are 5 main types of hepatitis viruses, referred to as types A, B, C, D and E. Twin studies of tuberculosis (TB) and the chronic HBV infection identified as the strong host genetic component to individual variability in case of disease susceptibility. Short-course chemotherapy containing the combination of Rifampicin plus Isoniazid has proved to be the highly effective in treatment of tuberculosis, but one of its adverse effects is hepatotoxicity. An estimated 49 million lives are saved through TB diagnosis and treatment between 2000 and 2015. Injection drug abusers, dialysis patients, sex workers, healthcare workers, patients with HIV infection, homeless people, persons in mental hospitals or prisons, and foreign-born persons of countries with highly prevalent HBV / hepatitis C and / or TB are at risk of exposure to both HBV and TB. HBV serology status can be predicted exactly on the basis of a Questionnaire algorithm, including a history of blood transfusion, IV drug abuse, younger age at sexual debut, and multiple sexual partners

Track 13 : Reproductive & Pediatric Infectious Diseases

Reproductive Infectious Disease is a subspecialty of Obstetrics & Gynecology that deals mainly with infections of women. These may be infections of the reproductive tract, infections during pregnancy, or any other infections that affect the life and well-being of women. Health care practitioners strives to provide the latest evidence-based treatments to women suffering from infectious diseases or related complications. In addition to providing care to women with HIV in pregnancy and beyond, the treatment for complicated or unusual post-operative infections, pelvic infections, and sexually transmitted infections.

Children are often at an increased risk for certain conditions while their immune systems are still developing. Because diagnosis and care for an infectious disease can be complex, it is important for the diagnose accurately and treat the child's condition. Children's comprehensive services providers include care for children with infectious diseases and epidemiological tracking that, for contagious conditions, helps limit the spread of infection and prevent further outbreaks like Bone and joint infections, Fever of unknown origins, HIV/AIDS, Infectious mononucleosis, Influenza, Lyme disease Meningitis, MRSA (methicillin-resistant staphylococcus aureus), Respiratory syncytial virus (RSV) Staph infections, Tuberculosis.

Best Care For Children

Children are not just small adults, their bodies are growing and have unique medical needs. They usually express their concerns differently than adults do. They cannot always answer medical questions, and are not always able to be patient and cooperative. Pediatric infectious diseases specialists know how to examine and treat children in a way that makes them relaxed and cooperative. They understand the unique signs, symptoms, treatments, outcomes/prognoses associated with infectious diseases in children, which can be quite different from those of adults with such infections.

Track 14 : Immunology of Infectious Diseases

The immune system is the host defence system composed of many biological structures and processes within an organism which protects against disease

The invulnerable reaction to a disease depends if the contamination is out of the blue or the contamination has happened previously. At the point once when the pathogens has just assaulted and has produced the memory cells in the host the reaction to the contamination will be exceptional on the following presentation. The invulnerable reaction to the remote body in the host is because of arrangement of other reaction from the resistant cells.

Despite whether compelling ailment administrator is the"old partner" or another, creating hazardous, the sheltered system's battle against it is normally the principal line of immune resistance. The safe response is the best way to destroy the irresistible illness when the drug is inaccessible.

Track 15 : Global Health security and Ebola Outbreak

Sexually transmitted diseases (STDs) remain the major Global public health challenge. Biological factors in women place at greater risk than men for the severe health consequences of STDs. The two major commonly reported infectious diseases in America is chlamydia and Gonorrhea which imposes a particular risk to the women’s health, as both can result in infertility if left untreated. Global Trends of STD are more toward viral origin as compare to bacterial origin. Epidemiology of infectious diseases helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

Track 16 : STDs and Pregnancy

Women who are pregnant can become infected (host vector) with the same STDs as women who are not pregnant. STDs and infectious diseases can complicate the pregnancy and may have serious effects on both mother and the developing baby. STDs/STIs during pregnancy can also cause Miscarriage, Ectopic pregnancy, Preterm labor and delivery, Birth defects and New born death etc. Some of the problems may be seen at birth; others may not be discovered until months or years later. Testing, diagnosis and treating the pregnant women for STDs and infections is the important way to prevent serious health complications to both mother and baby that may otherwise happen with infection. STDs, such as chlamydia, gonorrhea, syphilis, trichomoniasis and BV can all be treated with antibiotics that are safe to take during pregnancy.

Track 17 : Vaccines and Vaccination

Some STDs and infections, such as such as gonorrhea, Chlamydia, and syphilis, are caused by bacteria. They are usually effectively treated with antibiotics. Most of the STDs can be effectively prevented and treated through pre-exposure vaccination with widely available vaccines, including HAV, HBV, and HPV. Viral STDs are mostly highly persistent despite current therapeutic options or have no acceptable treatment available. Therefore, vaccines for certain viral STDs are in use, and others are in developmental process.

Track 18 : Trending Techniques in STDs

With STI surveillance reports, and ad hoc publications related to the distribution of STDs to describe recent trends in the epidemiology of major STIs due to Substantial morbidity, associated mortality, and disproportionate burden, marginalised communities, and those with high risk sexual lifestyles continue to drive their prioritisation in public health and policy arenas. With the newer diagnostic technologies, the verge of a major change in the approach to STI control by molecular amplification, Combination therapy, Stigma impairs cognition, proliferate and mimicking of human genome, immune receptor activation, potential treatment targets, Highly efficacious vaccines, Blocking of HIV DNA to cell nucleus, HIV transcription and latency, Mobile diagnostic tool, Novel antibiotic. When the choice of diagnostic methods are faster and results more accurate, they are bound to improve patient care. The molecular techniques, screening are useful for microorganisms that are difficult to culture. They are being increasingly accepted by clinicians as viable options in their practice. Aseptic technique is the normally applied to prevent the infections caused by different sources of infectious pathogens .

Track 19 : Diagnosis and Treatment

HIV infection can be diagnosed by serologic tests that detect antibodies against HIV-1 and HIV-2 and by virology tests that can detect HIV antigens or ribonucleic acid (RNA). Drug therapy or treatment for HIV is called Anti-Retroviral Therapy or ART. By proper medical care, treatment HIV can be controlled. Diagnosis and treatment for STDs should be screened for HIV infection. Women should be screened annually or yearly for cervical cancer precursor lesions by cervical Pap tests. Gonorrhea and chlamydia are bacterial STDs/STIs that can be treated by using potent antibiotics given either orally or by injection. Successful treatment for cancroid cures the infection, resolves the clinical symptoms, and prevents transmission to others.

Track 20 : Public Awareness

Sexually transmitted Infections (STIs) and Sexually Transmitted Diseases (STDs) which rank the most important health concerns for the people especially the young adults worldwide. The development of educational programs, awareness campaigns will play vital role in the fight to control sexually transmitted diseases. The Sexually Transmitted Disease (STD) infection prevention and control program works to reduce the incidence of sexually transmitted diseases. Social media practices to help implement awareness strategies. Awareness and knowledge was generally high for HIV/AIDS (above 90%) and low for HPV (range 5.4%-66%). By providing screening, testing, diagnosis and treatment for infected individuals, the STD program is fighting the war against STD’s for one person at a time. STDs can be simply prevented with three actions (a) Talk openly to partners, patients, and healthcare providers about sexual health and STDs, (b) Ensure everyone knows who should be tested and when, (c) The important role healthcare providers and patients play in making sure STDs are treated correctly.

Related Societies and Associations:

Europe: International AIDS Society (IAS) , Joint United Nations Programme on HIV and AIDS (UNAIDS) Spanish Society of Pediatric Infectious Diseases, Spain; Spanish Society of Pediatric Clinical immunology and Allergy, Spain; Spanish Association of Pediatric Primary Care, Spain, British Society for Immunology, U.K; European Society for Immune deficiencies, Switzerland.

USA: Association of Medical Microbiology, UK; Canadian Association for Clinical Microbiology and Infectious Diseases, Canada; National Institute of Allergy and Infectious Diseases, USA; Canadian Public Health Association, Canada; Tropical Pathology & Infectious Diseases Associations, Peru; International Society for Infectious Diseases, USA.

Asia Pacific: Philippine Hospital Infection Control Society, Philippine; New South Wales Infection Control Association, Australia; Victorian Infection Control Association, Australia; Victorian Infection Control Professionals Association, Australia; Infection Control Practitioners Association of Queensland, Australia.

Related Conferences

2nd Annual Congress on Bacterial, Viral and Infectious Diseases June 17-18, 2019 Dubai, UAE | World Congress on Advancements in Tuberculosis and Lung Diseases April 22-23, 2019, Tokyo, Japan | 12th Global Infections Conference September 09-10, 2019, Singapore | 6th International Congress on Infectious Diseases Feb 25-26, 2019 Heathrow, London, U.K | 7th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs July 01-02, 2019 Valencia, Spain | 15th World Congress on Infection Prevention and Control October 21-22, 2019 Zurich, Switzerland | 7th International Conference on HIV/AIDS, STDs and STIs March 18-19, 2019 New York, USA | 3rd International Conference on Influenza and Emerging Infectious Diseases April 10-11, 2019 | Toronto, Ontario, Canada | 4th International Conference on Infectious Diseases: Control and Prevention May 17-18, 2019 Philadelphia, Pennsylvania, USA| STI & HIV 2019 World congress 14 -17 July, 2019 Vancouver, Canada | 2nd World Congress on HIV AIDS STD and STI September 09-10, 2019 Bangkok, Thailand | SCON Summit on HIV and AIDS November 11-12, 2019 Las Vegas, USA | 2019 National HIV Prevention Conference March 18-21, 2019 Atlanta, Georgia.

STD Asia Pacific Congress 2019 conference is the global leading event which was held between continents and is organized in collaboration with regional STD and Infectious Diseases societies with the innovative theme “Advancements, Novel approaches for prevention & control of STD and Infectious Diseases”

Scope and Importance of STD & Infectious disease Research

According to recent statistical it was reported the abrupt increase in the death case studies was due to spread of infectious diseases and this infection and spreading could be prevented with the help of Health care professionals. Contamination aversion and control measures expect to guarantee the assurance of the individuals who may be powerless against procuring a disease. STDs are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS. STDs and HIV are linked by biological interactions in which infections can occur in the same populations. Infection with certain STDs can increase the risk of getting and transmitting HIV as well as alter the way the disease progresses. In addition, STDs can cause long-term health problems, particularly in women and infants. Some of the health complications that arise from STDs include pelvic inflammatory disease, infertility, tubal or ectopic pregnancy, cervical cancer, and perinatal or congenital infections in infants born to infected mothers. The global concerns of sexually transmitted infections (STIs) remains at the higher edge.

Why Japan?

HIV/AIDS has been a global phenomenon due to the delay in the research, development and health care sector. The reported number of cases for the HIV in females of Japan is 459 and 169 for AIDS science the beginning of surveillance in 1984 through the end of 2003 where most of them are affected by heterosexual contact. The rate of the number of people diagnosed with HIV/AIDS is increasing with 30 people annually.

Examining data by age group, there is a drastic increase among young people. In the age group 15-24, female HIV/AIDS cases exceed males (70.6% of ages 15-19 and 55.1% of ages 20-24 in HIV reported cases are female. These age groups are distinctive from other age groups where the majority is male). HIV positive pregnant women make up less than 1% of the total number in the report, but some data suggests that a higher rate is expected than that of non-pregnant women in some regions. In these situations, prevention measures for young people are considered to be a top priority.

Increase in the Global STD diagnostics market, by types, 2012-2022, (USD Billion)

In STD Asia Pacific 2018 conference has been fostering the need to control the impact of permanent Sexually transmitted infections within the public health environment. The STD diagnostics industry is estimated to experience growth majorly due to rising prevalence of various infections such as chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, chancroid, and other infections including trichomonas vaginalis and vaginitis.

Bacterial STIs include gonorrhea, chlamydia, and syphilis while viral STIs include genital herpes, HIV, genital warts (HPV), and hepatitis. The microorganisms causing STIs reside in blood, semen, and vaginal fluid. STDs caused by chlamydia dominated the overall market in terms of revenue and was valued at around USD 6.00 billion in 2014. However, diagnosis of sexually transmitted diseases caused by syphilis is rising and is estimated to account for over 20% of the market by 2022, growing at a healthy CAGR over the forecast period due to increasing prevalence of syphilis infections worldwide.

Statistics of Marketers, Researchers working on STD and infectious diseases

Case report for curable STD :

In 2012, there were an estimated 357 million new infections (roughly 1 million per day) of the four curable STIs – chlamydia, gonorrhoea, syphilis and trichomoniasis. Prevention and control of STIs are an integral component of the comprehensive sexual and reproductive health services needed to attain the Sustainable Development Goals (SDGs) to reduce child and neonatal mortality (3.2), to end the epidemics of AIDS and other communicable diseases (3.3), to reduce non communicable diseases, and to improve mental health (3.4), sexual and reproductive health (3.7) and to achieve universal health coverage (3.8). Surveillance is a key element of the World Health Organization (WHO) STI prevention and control strategy and is an important component of second-generation surveillance systems for human immunodeficiency virus (HIV).

Global estimates of new cases of curable STIs in 2012-2018

Considering the abortion rates and the STD count it is been observed that women in their teens to early 20s are considered to be the high risk group. Some studies show that sexual contact with irregular partners are very common in young people, and the ratio of condoms use is low with regular partners and even lower with irregular partners.

Vulnerable group in women is not only young people. Women over 55 were the least likely to use condoms comparing with other age groups. Menopause is considered to be one of the reasons for not using condoms, as contraception is no longer an issue for them.

The abortion rate in 2002 is highest among women in their early 20s (20.3%), but it has also been found that women in their late 20s and 30s have rates as high as 12 to 15%. In these groups, the rate of condom use is decreased. Regarding women and HIV/AIDS, mother-to-child transmission has always been considered as a major issue in the medical or public arena while other topics have been rarely discussed. Nowadays, transmission from HIV-infected women to their infants can be reduced to 2% by provision of antiretroviral drugs, safe delivery practices and avoiding breastfeeding.

Fund Allotment to STD and Infectious diseases Research

Domestic funding is STD and infectious disease spending, by country governments in their national budgets. The Global Fund , The World Bank , The United Nations are the Key Multilateral funding Institutions Involved in STD, HIV/AIDS and other infectious diseases. Historically, the HIV response has been largely funded by international donors and governments, but low- and middle-income countries are now beginning to lead on efforts to finance their STD response. The President’s Emergency Plan for AIDS Relief (PEPFAR), USA-WHO accounted for the majority of bilateral and multilateral funding from donor governments in 2017 (US$4.9 billion), followed by the United Kingdom (UK) (US$645.6 million), France (US$242.4 million), the Netherlands (US$214.2 million) and Germany (US$182 million), these five countries have accounted for roughly 80% of all HIV funding from donor governments.

Private funders The charitable and corporate philanthropic organisations provided US$680 million for global STD,HIV and AIDS programmes in 2017.The largest funders — The Bill and Melinda Gates Foundation and Gilead Sciences ViiV Healthcare, Aidsfonds, Kaiser Family Foundation and Elton John AIDS Foundation.

African Union (AU) endorses major new initiatives to end up AIDS by 2030 .The Joint United Nations Programme on STD and Infectious diseases (UNAIDS)with Abuja Declaration leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNITAID, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank which works closely with global and national partners towards ending the STD, HIV and AIDS epidemic by 2030 as part of the Sustainable Development.

Japan International Cooperation Agency (JICA); Ministry of Foreign Affairs (MOFA); Ministry of Health; Ministry of Finance; Japan Bank for International Cooperation (JBIC); Japan International Corporation of Welfare Services (JICWELS)

Japanese Societies associated with STD and Infectious Diseases

The Japan Society of Medical History	The Japanese Society of Pathology
Japanese Association of Anatomists	The Japanese Cancer Association
Physiological Society of Japan	The Japanese Society of Hematology
The Japanese Biochemical Society	Japanese Society for Bacteriology
The Japanese Pharmacological Society	The Japanese Society of Parasitology
The Infectious Diseases Society of America	Japanese Society of Legal Medicine
Japanese Society for Hygiene	The Japanese Society of Health and Human Ecology
Japan Society of Nutrition and Food Science	The Japanese Society of Balneology, Climatology and Physical Medicine
The Japan Endocrine Society	The Japanese Society of Internal Medicine
Japan Pediatric Society	The Japanese Association for Infectious Disease
The Japanese Dermatological Association	The Japanese Society for Virology
American Society for Microbiology	Australian Society for Microbiology
Australian Society of Antimicrobials	Philippine Society for Microbiology
French Society for Microbiology	Society of Tropical Medicine and Infectious Diseases
Society for Applied Microbiology	American Society for Virology
The Japanese Society of Internal Medicine	Japanese Society for infection Prevention and control
The Japanese Association for Infectious Diseases

Major Manufacturing Companies associated with STA and Infectious Diseases in Japan

Major companies operating in the STD diagnostics arena include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, bioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure. These companies focus on the partnership and product/technology licensing opportunities in the sexually transmitted diseases diagnostics industry. Below are the Products Manufacturing Companies for Infectious Diseases and STD in Japan

Shigematsu Co., Ltd
Shionogi
ViroQuest
ViiV Healthcare Ltd.
Otsuka Pharmaceutical
Mogi Pharmaceutical Co., Ltd.
Alfresa Holdings Corporation
Mogi Pharmaceutical Co., Ltd.
Alfresa Pharma Corporation
Wakunaga Pharmaceutical
ARKRAY
Oncolys BioPharma
BioReliance (SAFC)
IDAC Theranostics
Mochida Pharmaceutical
Nippon Kayaku

Counseling and Support Services in Japan:

TELL (Tokyo English Life Line)

Gifu AIDS Support (Telephone Counseling and Support Group in Gifu)

Japan HIV Center (Telephone Counseling and Support Group in Nagoya)

JaNP+ (Network for People with HIV/AIDS in Japan)

Life AIDS Project (Social Support for PLWHA)

HEARTY NETWORK (Gay HIV+ Support Group)

Japan Major Universities and research associated with STD and Infectious Diseases in Japan

References :

http://aidsinfo.unaids.org/

http://www.aidsmap.com/

https://www.ilga-europe.org/

https://www.one.org/international/issues/infectious-diseases/

https://www.cdc.gov/

http://www.who.int/en

http://documents.worldbank.org/curated/en/home

http://youact.org/

http://www.emcdda.europa.eu/

https://www.eurosurveillance.org/

https://www.thelancet.com/

https://idpc.net/

https://www.hri.global/

https://reliefweb.int/

https://www.avert.org/

https://ecdc.europa.eu/en/home

https://www.hiv.gov/

https://ourworldindata.org/hiv-aids

http://www.aidsinfoonline.org/gam/libraries/aspx/home.aspx

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	October 21-22, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

9^th Asia Pacific STD and Infectious Diseases Congress October 21-22, 2019 Tokyo, Japan

Recommended Global Infectious Diseases Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

STD Asia Pacific Congress 2019

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

Conference Series Destinations

Webinars & Conferences By Continents

Americas

Asia-Pacific

Europe

Medical & Clinical Webinars & Conferences

Webinars & Conferences By Subject